Pharmacological evidence for cardiac muscarinic receptor subtypes.
The chronotropic and inotropic effects of muscarinic receptor agonists (Acetylcholine, Arecoline, Carbachol, Furtrethonium) and antagonists (Atropine, N-methyl and N-butyl scopolammonium, pirenzepine) on isolated guinea-pig atria were studied. All had a greater affinity constants for muscarinic receptors as assessed in terms of inotropic effects than in terms of chronotropic effects. This difference, well correlated with the pharmacological effect, suggests the occurrence of cardiac muscarinic receptor subtypes, one mediating heart rate and the other contractile force. The ratio of chronotropic to inotropic potencies for each agent shows that the physiological mediator. Acetylcholine, differentiates best between the two subtypes, while atropine is the least discriminatory.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001115:Arecoline / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001570:Benzodiazepinones / Q000494:pharmacology; D001665:Binding Sites; D002086:Butylscopolammonium Bromide / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects*; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism; D019832:N-Methylscopolamine; D010890:Pirenzepine; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D011976:Receptors, Muscarinic / Q000378:metabolism*; D012602:Scopolamine Derivatives / Q000494:pharmacology
D001570:Benzodiazepinones; D000644:Quaternary Ammonium Compounds; D011976:Receptors, Muscarinic; D012602:Scopolamine Derivatives; D002086:Butylscopolammonium Bromide; D010890:Pirenzepine; D001115:Arecoline; D001285:Atropine; D002217:Carbachol; C028530:furtrethonium; D000109:Acetylcholine; D019832:N-Methylscopolamine